About Cardiosense
Cardiosense is a company based in Chicago (United States) founded in 2020 by Amit Gupta, Avi Kazen, and Andrew Carek.. Cardiosense has raised $15.1 million across 1 funding round from investors including UnityPoint Health, Broadview Ventures and Hatteras Venture Partners. Cardiosense offers products and services including CardioTag Sensor, Wavesense Platform, and Clinical AI. Cardiosense operates in a competitive market with competitors including Tyto Care, AliveCor, Edwards Lifesciences, BioIntelliSense and Endotronix, among others.
- Headquarter Chicago, United States
- Founders Amit Gupta, Avi Kazen, Andrew Carek
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cardiosense, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.1 M (USD)
in 1 rounds
-
Latest Funding Round
$15.1 M (USD), Series A
Dec 08, 2022
-
Investors
UnityPoint Health
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cardiosense
Cardiosense offers a comprehensive portfolio of products and services, including CardioTag Sensor, Wavesense Platform, and Clinical AI. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medical-grade wearable for wireless patient monitoring and data collection.
Device-agnostic system for aggregating and analyzing physiological sensor data.
Applies deep learning to raw waveforms for early cardiac disease detection.
Unlock access to complete
Unlock access to complete
Funding Insights of Cardiosense
Cardiosense has successfully raised a total of $15.1M through 1 strategic funding round. The most recent funding activity was a Series A round of $15.1 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $15.1M
-
First Round
First Round
(08 Dec 2022)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Series A - Cardiosense | Valuation | Broadview Ventures , Hatteras Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cardiosense
Cardiosense has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include UnityPoint Health, Broadview Ventures and Hatteras Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
UnityPoint Health is recognized for providing comprehensive healthcare services.
|
Founded Year | Domain | Location | |
|
Seed-stage life sciences investments are made in the US.
|
Founded Year | Domain | Location | |
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cardiosense
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cardiosense
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cardiosense Comparisons
Competitors of Cardiosense
Cardiosense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tyto Care, AliveCor, Edwards Lifesciences, BioIntelliSense and Endotronix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical consultations are facilitated via self-exams and remote diagnostic devices.
|
|
| domain | founded_year | HQ Location |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| domain | founded_year | HQ Location |
Medical devices for structural heart disease are developed and provided.
|
|
| domain | founded_year | HQ Location |
Vital signs are monitored via a single-use patch and platform.
|
|
| domain | founded_year | HQ Location |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| domain | founded_year | HQ Location |
Remote monitoring platform for tracking patient activity
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cardiosense
Frequently Asked Questions about Cardiosense
When was Cardiosense founded?
Cardiosense was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Where is Cardiosense located?
Cardiosense is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Who is the current CEO of Cardiosense?
Amit Gupta is the current CEO of Cardiosense. They have also founded this company.
Is Cardiosense a funded company?
Cardiosense is a funded company, having raised a total of $15.1M across 1 funding round to date. The company's 1st funding round was a Series A of $15.1M, raised on Dec 08, 2022.
What does Cardiosense do?
Cardiosense was founded in 2020 and is headquartered in Chicago, United States. Operations focus on the healthcare sector, where AI-based devices for cardiac monitoring are supplied to providers. A physiological waveform data platform is being developed, incorporating multi-modal sensors and AI algorithms to generate predictive biomarkers. These support pre-symptomatic disease detection and facilitate personalized therapy options.
Who are the top competitors of Cardiosense?
Cardiosense's top competitors include Tyto Care, AliveCor and Endotronix.
What products or services does Cardiosense offer?
Cardiosense offers CardioTag Sensor, Wavesense Platform, and Clinical AI.
Who are Cardiosense's investors?
Cardiosense has 6 investors. Key investors include UnityPoint Health, Broadview Ventures, Hatteras Venture Partners, Laerdal Million Lives Fund, and Portal Innovations.